Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue SUPPL. 2, 2004, Pages 14593-14598

  Arnon, Ruth ^a   Aharoni, Rina ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN A; GAMMA INTERFERON; GLATIRAMER; INTERLEUKIN 10; MYELIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; CELL MIGRATION; COLITIS; COLON INJURY; CONFERENCE PAPER; DRUG BINDING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MORTALITY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SUPPRESSOR CELL; TH2 CELL; WEIGHT REDUCTION;

EID: 5144233487     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0404887101     Document Type: Article

References (38)

1. Teitelbaum, D., Meshorer, M., Hirshfeld, T., Sela, M. & Arnon, R. (1971) Eur. J. Immunol. 1, 242-248.
2. Arnon, R. (1996) Immunol. Lett. 50, 1-15.
3. Simson, D., Noble, S. & Perry, C. (2002) CNS Drugs 16, 825-850.
4. Webb, C., Teitelbaum, D., Arnon, R. & Sela, M. (1973) Eur. J. Immunol. 3, 279-286.
5. Fridkis-Hareli, M., Teitelbaum, D., Gurevich, E., Pecht, I., Brautbar, C., Kwon, O. J., Brenner, T., Arnon, R. & Sela, M. (1994) Proc. Natl. Acad. Sci. USA 9, 4872-4876.
6. Vieira, P. L., Heystek, H. C., Wormmeester, J., Wierenga, E. A. & Kapsenberg, M. L. (2003) J. Immunol. 170, 4483-4484.
7. Aharoni, R., Teitelbaum, D., Arnon, R. & Sela, M. (1999) Proc. Natl. Acad. Sci. USA 96, 634-639.
8. Lando, Z., Teitelbaum, D. & Arnon, R. (1979) J. Immunol. 132, 2156-2160.
9. Aharoni, R., Teitelbaum, D. & Arnon, R. (1993) Eur. J. Immunol. 23, 17-25.
10. Aharoni, R., Teitelbaum, D. & Sela, M. (1996) Proc. Natl. Acad. Sci. USA 94, 10821-10826.
11. Aharoni, R., Teitelbaum, D., Sela, M. & Arnon, R. (1998) J. Neuroimmunol. 91, 135-146.
12. Miller, A., Shapiro, S., Gershtein, R., Kinarti, A., Rawashdeh, H., Honigman, S. & Lahat, N. (1988) J. Neuroimmunol. 92, 113-121.
13. Neuhaus, O., Farina, C., Yassouridis, A., Wiendl, H., Bergh, F., Dose, T., Wekerle, H. & Hohlfeld, R. (2000) Proc. Natl. Acad. Sci. USA 97, 7452-7457.
14. Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I. & Hafler, D. A. (2000) J. Clin. Invest. 105, 967-976.
15. Aharoni, R., Teitelbaum, D., Leitner, O., Meshorer, A., Sela, M. & Arnon, R. (2000) Proc. Natl. Acad. Sci. USA 97, 11472-11477.
16. Aharoni, R., Meshorer, A., Sela, M. & Arnon, R. (2002) J. Neuroimmunol. 126, 58-68.
17. Aharoni, R., Kayhan, B., Eilam, R., Sela, M. & Arnon, R. (2003) Proc. Natl. Acad. Sci. USA 100, 14157-14162.
18. Kennedy, M. K., Torrance, D. S., Picha, K. S. & Mohler, K. M. (1992) J. Immunol. 149, 2496-2505.
19. Bettelli, E., Nicholson, L. B. & Kuchroo, V. (2003) J. Autoimmun. 20, 265-267.
20. Ledeboer, A., Breve, J. P., Poole, S., Tilders, F. J. & Van Dam, A. M. (2000) Glia 30, 134-142.
21. Morris, M. M., Dyson, H., Baker, D., Harbige, L. S., Fazakerley, J. K. & Amor, S. (1997) J. Neuroimmunol 74, 185-197.
22. Thoenen, H. (1995) Science 270, 593-598.
23. Barde, Y. A. (1997) Nature 385, 391-393.
24. Gravel, C., Gotz, R., Lorrain, A. & Sendtner, M. (1997) Nat. Med. 3, 765-770.
25. Stadelmann, C., Kerschensteiner, M., Misgeld, T., Bruck, W., Hohlfeld, R. & Lassman, R. (2002) Brain 125, 75-85.
26. Sykes, M. (1996) FASEB J. 10, 721-730.
27. Auchincloss, H., Jr., & Sultan, H. (1996) Curr. Opin. Immunol. 8, 681-687.
28. Nickerson, P., Steurer, W., Steiger, J., Zheng, X., Steele, A. W. & Strom, T. B. (1994) Curr. Opin. Immunol. 6, 757-764.
29. Schlegel, P. G., Aharoni, R., Chen, Y., Chen, J., Teitelbaum, D., Arnon, R., Sela, M. & Chao, N. J. (1996) Proc. Natl. Acad. Sci. USA 93, 5061-5066.
30. Masri, M. A. (2003) Mol. Immunol. 39, 1073-1077.
31. Ma, A. & Chen, H. (2002) Curr. Drug Targets Cardiovasc. Haematol. Discord. 2, 57-71.
32. Aharoni, R., Teitelbaum, D., Arnon, R. & Sela, M. (2001) Transplantation 27, 598-605.
33. Aharoni, R., Yussim, A., Sela, M. & Arnon, R. (2004) Int. Immunopharmacol., in press.
34. Aharoni, R., Schlegel, P. G., Teitelbaum, D., Roikhel-Karpov, O., Chen, Y., Arnon, R., Sela, M. & Chao, N. J. (1997) Immunol. Lett. 58, 79-87.
35. Shanahan, F. (2001) Gastroenterology 120, 622-635.
36. Sandborn, W. J. & Targan, S. R. (2002) Gastroenterology 122, 1592-1608.
37. Van Deventer, S. J. H. (2000) Scand. J. Immunol. 51, 18-22.
38. Witz, S. & Neurath, M. F. (2000) Int. J. Colorectal Dis. 15, 144-160.